UBS Group’s Titan Medical Inc. Ordinary Shares TMDI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-100
Closed -$66 11330
2022
Q4
$66 Sell
100
-26,139
-100% -$13.8K ﹤0.01% 10451
2022
Q3
$12K Sell
26,239
-1,301
-5% -$675 ﹤0.01% 8242
2022
Q2
$14K Buy
27,540
+27,440
+27,440% +$13.4K ﹤0.01% 7455
2022
Q1
$0 Sell
100
-13,792
-99% -$8K ﹤0.01% 11319
2021
Q4
$9K Sell
13,892
-26,149
-65% -$29.5K ﹤0.01% 8974
2021
Q3
$61K Buy
40,041
+25,703
+179% +$41.7K ﹤0.01% 6185
2021
Q2
$24K Buy
14,338
+14,238
+14,238% +$24.6K ﹤0.01% 7169
2021
Q1
$0 Sell
100
-9,336
-99% -$20.9K ﹤0.01% 9687
2020
Q4
$17K Sell
9,436
-5,346
-36% -$5.31K ﹤0.01% 7078
2020
Q3
$10K Buy
14,782
+14,682
+14,682% +$11.6K ﹤0.01% 6883
2020
Q2
$0 Sell
100
-25,256
-100% -$12.9K ﹤0.01% 8513
2020
Q1
$7K Buy
25,356
+24,037
+1,822% +$9.57K ﹤0.01% 7178
2019
Q4
$0 Buy
1,319
+887
+205% +$545 ﹤0.01% 8536
2019
Q3
$0 Sell
432
-84
-16% -$176 ﹤0.01% 8376
2019
Q2
$2K Buy
516
+250
+94% +$626 ﹤0.01% 7658
2019
Q1
$1K Sell
266
-3,774
-93% -$12.4K ﹤0.01% 7593
2018
Q4
$5K Buy
4,040
+3,774
+1,419% +$6.99K ﹤0.01% 7580
2018
Q3
$1K Buy
266
+34
+15% +$96 ﹤0.01% 7876
2018
Q2
$1K Buy
+232
New +$1.39K ﹤0.01% 7864

Other funds holding TMDI

UBS Group's TMDI Position: Q1 2023 in Review

UBS Group sold out of Titan Medical Inc. Ordinary Shares (TMDI) in Q1 2023, closing a stake of 100 shares — an estimated $66 sold.

UBS Group first reported a position in TMDI in Q2 2018 and held it in 19 quarters. The position peaked at $61K in Q3 2021. 12 funds tracked by Wall St. Rank hold TMDI as of Q1 2023.

  • UBS Group reported no remaining Titan Medical Inc. Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • UBS Group sold 100 Titan Medical Inc. Ordinary Shares shares in Q1 2023, an estimated $66.
  • UBS Group first reported a position in Titan Medical Inc. Ordinary Shares in Q2 2018 and held it in 19 quarters.
  • UBS Group's Titan Medical Inc. Ordinary Shares position peaked at $61K in Q3 2021.
  • 12 funds tracked by Wall St. Rank held Titan Medical Inc. Ordinary Shares as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.